Home
>
National Drug Code (NDC)
>
Typhim Vi
Typhim Vi - 49281-790-20 - (SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN)
Drug Information of Typhim Vi
| Product NDC: | 49281-790 |
| Proprietary Name: | Typhim Vi |
| Non Proprietary Name: | SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN |
| Active Ingredient(s): | 25 ug/.5mL & nbsp; SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Typhim Vi
| Product NDC: | 49281-790 |
| Labeler Name: | Sanofi Pasteur Inc. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA103936 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19941128 |
Package Information of Typhim Vi
| Package NDC: | 49281-790-20 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-790-20) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Typhim Vi
| NDC Code | 49281-790-20 |
| Proprietary Name | Typhim Vi |
| Package Description | 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-790-20) > 10 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 49281-790 |
| Product Type Name | VACCINE |
| Non Proprietary Name | SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19941128 |
| Marketing Category Name | BLA |
| Labeler Name | Sanofi Pasteur Inc. |
| Substance Name | SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN |
| Strength Number | 25 |
| Strength Unit | ug/.5mL |
| Pharmaceutical Classes | Inactivated Salmonella Typhi Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Vaccines, Typhoid [Chemical/Ingredient],VI Polysaccharide Vaccine, Typhoid [Chemical/Ingredient] |
